The interactions and interdependence of growth factor receptors such as the HER family and integrins are underscored by observations such that β1-integrin can facilitate bypassing of the anti-proliferative effects of the HER2 neutralizing antibody, trastuzumab, in breast cancer cells [52]. The gene discussed is ERBB2; the disease is breast cancer.